Literature DB >> 21997942

Factors associated with typhoid relapse in the era of multiple drug resistant strains.

Kaashif Aqeeb Ahmad1, Liaqat Hayat Khan, Bakht Roshan, Zulfiqar Ahmed Bhutta.   

Abstract

INTRODUCTION: Typhoid has an estimated global burden of greater than 27 million cases per annum with a clinical relapse rate of 5% to 20%.  Despite the large relapse burden, the factors associated with relapse are largely unknown.
METHODOLOGY: We have followed a protocol for the diagnosis and management of pediatric typhoid since 1988.  We report factors associated with relapse of culture-proven enteric fever in 1,650 children presenting to the Aga Khan University Medical Center,  Karachi, Pakistan, over a 15-year period.
RESULTS: In those infected with multiple drug resistant (MDR) strains, factors associated with subsequent relapse include constipation at presentation and presentation within 14 days of fever onset.  Diarrhoea in those children infected with drug sensitive strains had an association with decreased subsequent relapse, as was quinolone therapy.
CONCLUSIONS: Multiple clinical factors at presentation are associated with subsequent typhoid fever relapse.  These factors may be postulated to be associated with subsequent relapse due to alterations in the reticuloendothelial system organism load.  These data will be valuable in developing algorithms for clinical follow-up in children infected with MDR enteric fever.

Entities:  

Mesh:

Year:  2011        PMID: 21997942     DOI: 10.3855/jidc.1192

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  5 in total

1.  Salmonella enterica serotype Typhi infections in a Canadian pediatric hospital: a retrospective case series.

Authors:  Jeannette L Comeau; Thai Hoa Tran; Dorothy L Moore; Chi-Minh Phi; Caroline Quach
Journal:  CMAJ Open       Date:  2013-05-02

Review 2.  Relapse of typhoid fever following delayed response to meropenem: A case report and review of previously published cases indicating limited clinical efficacy of meropenem for the treatment of typhoid fever.

Authors:  Christian G Blumentrath; Gernot Müller; Dieter Teichmann; Jens Tiesmeier; Jasmina Petridou
Journal:  Ger Med Sci       Date:  2019-01-07

3.  An alternative penicillin-binding protein involved in Salmonella relapses following ceftriaxone therapy.

Authors:  Sónia Castanheira; David López-Escarpa; M Graciela Pucciarelli; Juan J Cestero; Fernando Baquero; Francisco García-Del Portillo
Journal:  EBioMedicine       Date:  2020-04-25       Impact factor: 8.143

4.  The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles.

Authors:  Catherine J Reynolds; Claire Jones; Christoph J Blohmke; Thomas C Darton; Amelie Goudet; Ruhena Sergeant; Bernard Maillere; Andrew J Pollard; Daniel M Altmann; Rosemary J Boyton
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

5.  Salmonella enterica Serovar Typhi: An Unusual Cause of Infective Endocarditis.

Authors:  Christopher Robson; Matthew V N O'Sullivan; Shobini Sivagnanam
Journal:  Trop Med Infect Dis       Date:  2018-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.